Orange Book product · Brand (NDA)
INZIRQO
HYDROCHLOROTHIAZIDE
At a glance
Jan 28, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 28, 2025
1 yr 5 mo ago
Today
Patent 11878022 expires
Listed drug product patent expiration.
Jan 23, 2044
in 17 yr 10 mo
Patent 11878022 expires
Listed drug product patent expiration.
Jan 23, 2044
in 17 yr 10 mo
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE
Strength
10MG/ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 219141
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 1996MICROZIDEBrand (NDA)
NDA 020504 · TEVA BRANDED PHARM
- —ESIDRIXBrand (NDA)
NDA 011793 · NOVARTIS
- 2024HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 083177 · IVAX SUB TEVA PHARMS
- 2023HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 085182 · HERITAGE
- 2019HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 203561 · SCIEGEN PHARMS
- 2014HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090651 · SUN PHARM INDS INC
- 2012HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202556 · ACCORD HLTHCARE
- 2012HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 091662 · CHARTWELL MOLECULAR
- 2010HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 200645 · ALEMBIC PHARMS LTD
- 2010HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090510 · UNICHEM
- 2009HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 079237 · IPCA LABS LTD
- 2008HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 078389 · APOTEX
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11878022 | Jan 23, 2044 | in 17 yr 10 mo | ProductU-4138 |
| 11878022 | Jan 23, 2044 | in 17 yr 10 mo | ProductU-4139 |

